Oncology ASCO 2025: Breast cancer breakthroughs drive HCPs’ online co... Every year at ASCO, we see new data. New combinations. New standards of care.
News Old COVID tweet lands Pfizer in new trouble with PMCPA COVID-19 vaccine tweets from 2020 land Pfizer in trouble for promoting an unlicensed medicine - and reveal the pitfalls of linking content.
Oncology Prostate cancer: HCPs discuss emerging treatments, artificia... In March, the UK marked Prostate Cancer Awareness Month - a period dedicated to boosting recognition and tackling stigma of a cancer that affects approximately one in eight men nationwide.<
News Novo Nordisk returns to ABPI fold after two-year suspension Novo Nordisk has reached the end of its two-year suspension from the ABPI for breaches of its code of practice after making "sustained improvements."
News EMA abandons X in favour of rival Bluesky The EMA has abandoned X for Bluesky, saying Elon Musk's social media platform "no longer suits our communication needs."
Sales & Marketing Unpacking EASD 2024: Key themes, topics, and influencers This September, Madrid played host to the 60th Annual Meeting of the European Association for the Study of Diabetes (EASD).
Market Access The value of a partner, globally and locally A new podcast looks at recent trends related to drug approvals, as well as challenges and opportunities both small and large pharma companies face